drugset / Trial / NCT05926856

High Quality Fluorescent Cholangiography

NCT05926856

Phase 2/3 Completed 168 enrolled Zhujiang Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

The goal of this randomized controlled trial is to compare the quality of extrahepatic biliary fluorescent visualization under two injection protocols to optimize extrahepatic biliary cholangiography.

Timeline

Start
2023-08-04
Primary completion
2023-12-11
Completion
2023-12-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Indocyanine Green Diagnostic / imaging agent 0.05 mg/kg
Subject Indocyanine Green Diagnostic / imaging agent 0.25 mg/kg

Indications